Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemorrhoids | 5 | 2023 | 14 | 2.630 |
Why?
|
Endoscopy, Gastrointestinal | 16 | 2014 | 370 | 1.940 |
Why?
|
Fissure in Ano | 2 | 2020 | 8 | 1.410 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 6 | 2019 | 175 | 1.120 |
Why?
|
Ligation | 4 | 2023 | 192 | 0.930 |
Why?
|
Pancreatitis | 4 | 2019 | 284 | 0.770 |
Why?
|
Diverticulum | 1 | 2019 | 36 | 0.650 |
Why?
|
Duodenal Diseases | 1 | 2019 | 44 | 0.640 |
Why?
|
Light Coagulation | 1 | 2018 | 18 | 0.630 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2018 | 116 | 0.570 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 417 | 0.510 |
Why?
|
Curriculum | 3 | 2019 | 916 | 0.500 |
Why?
|
Jejunostomy | 1 | 2014 | 54 | 0.470 |
Why?
|
Gastroenterology | 4 | 2020 | 206 | 0.470 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2005 | 352 | 0.460 |
Why?
|
Intubation, Gastrointestinal | 1 | 2014 | 87 | 0.460 |
Why?
|
Constipation | 2 | 2022 | 181 | 0.430 |
Why?
|
Gastrostomy | 1 | 2014 | 189 | 0.420 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 716 | 0.410 |
Why?
|
Esophageal and Gastric Varices | 2 | 2005 | 91 | 0.400 |
Why?
|
Enteral Nutrition | 1 | 2014 | 337 | 0.390 |
Why?
|
Primary Health Care | 1 | 2018 | 858 | 0.390 |
Why?
|
Lichen Planus, Oral | 1 | 2010 | 9 | 0.380 |
Why?
|
Androstadienes | 1 | 2010 | 172 | 0.340 |
Why?
|
Barrett Esophagus | 2 | 2007 | 572 | 0.340 |
Why?
|
Deglutition Disorders | 2 | 2010 | 475 | 0.310 |
Why?
|
Colonoscopy | 6 | 2017 | 527 | 0.310 |
Why?
|
Anal Canal | 2 | 2020 | 244 | 0.300 |
Why?
|
Capsule Endoscopy | 1 | 2007 | 26 | 0.300 |
Why?
|
Intestine, Small | 2 | 2015 | 513 | 0.290 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 471 | 0.290 |
Why?
|
Cholangitis | 1 | 2006 | 49 | 0.270 |
Why?
|
Hemostasis, Endoscopic | 1 | 2005 | 34 | 0.260 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2006 | 14 | 0.260 |
Why?
|
Helicobacter pylori | 5 | 2004 | 1321 | 0.250 |
Why?
|
Helicobacter Infections | 5 | 2004 | 1245 | 0.250 |
Why?
|
Ulcer | 1 | 2005 | 77 | 0.240 |
Why?
|
Biotechnology | 1 | 2004 | 72 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 530 | 0.230 |
Why?
|
Intestinal Diseases | 1 | 2005 | 126 | 0.230 |
Why?
|
Lactation | 1 | 2005 | 220 | 0.220 |
Why?
|
Humans | 50 | 2023 | 270969 | 0.220 |
Why?
|
Pregnancy Complications | 2 | 2022 | 544 | 0.210 |
Why?
|
Anus Diseases | 1 | 2022 | 29 | 0.210 |
Why?
|
Bacterial Infections | 1 | 2006 | 486 | 0.210 |
Why?
|
Cathartics | 2 | 2017 | 43 | 0.200 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2002 | 38 | 0.200 |
Why?
|
Stomach Neoplasms | 4 | 2009 | 2349 | 0.190 |
Why?
|
Gastrointestinal Diseases | 2 | 2006 | 602 | 0.190 |
Why?
|
Biliary Tract Diseases | 2 | 2014 | 63 | 0.180 |
Why?
|
Endoscopy | 1 | 2023 | 498 | 0.180 |
Why?
|
Botulinum Toxins | 1 | 2002 | 136 | 0.180 |
Why?
|
Peritoneal Neoplasms | 1 | 2006 | 835 | 0.170 |
Why?
|
Sclerotherapy | 1 | 1999 | 50 | 0.160 |
Why?
|
Zollinger-Ellison Syndrome | 1 | 1998 | 7 | 0.160 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 1093 | 0.160 |
Why?
|
Proctoscopy | 1 | 2018 | 17 | 0.160 |
Why?
|
Cholecystectomy | 1 | 2019 | 116 | 0.160 |
Why?
|
Cholestasis, Intrahepatic | 1 | 1999 | 74 | 0.150 |
Why?
|
Gastrectomy | 3 | 2009 | 480 | 0.150 |
Why?
|
Esophagoscopy | 2 | 2010 | 306 | 0.150 |
Why?
|
United States | 6 | 2019 | 16325 | 0.150 |
Why?
|
Outpatients | 1 | 2019 | 475 | 0.140 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 246 | 0.120 |
Why?
|
Capsules | 2 | 2005 | 54 | 0.120 |
Why?
|
Patient Readmission | 1 | 2019 | 600 | 0.120 |
Why?
|
Wound Healing | 1 | 2020 | 829 | 0.120 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 206 | 0.120 |
Why?
|
Pancreatic Diseases | 2 | 2005 | 110 | 0.120 |
Why?
|
Pregnancy | 3 | 2022 | 7898 | 0.110 |
Why?
|
Prevalence | 2 | 2018 | 3399 | 0.110 |
Why?
|
Rotavirus Infections | 1 | 2015 | 287 | 0.110 |
Why?
|
Rotavirus | 1 | 2015 | 376 | 0.110 |
Why?
|
Ascitic Fluid | 1 | 1992 | 79 | 0.100 |
Why?
|
Population Surveillance | 2 | 2006 | 642 | 0.100 |
Why?
|
Punctures | 1 | 1992 | 109 | 0.100 |
Why?
|
Virus Replication | 1 | 2015 | 715 | 0.100 |
Why?
|
Anti-Bacterial Agents | 3 | 2006 | 3119 | 0.100 |
Why?
|
Gastric Mucosa | 2 | 2009 | 624 | 0.100 |
Why?
|
Models, Theoretical | 1 | 2015 | 795 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 9020 | 0.090 |
Why?
|
Omeprazole | 2 | 2004 | 93 | 0.090 |
Why?
|
Fluticasone | 1 | 2010 | 23 | 0.090 |
Why?
|
Portal Vein | 1 | 1992 | 366 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2009 | 10282 | 0.080 |
Why?
|
Dissection | 1 | 2009 | 155 | 0.080 |
Why?
|
Female | 13 | 2022 | 147624 | 0.080 |
Why?
|
Endosonography | 3 | 2009 | 545 | 0.080 |
Why?
|
Anti-Ulcer Agents | 2 | 1999 | 106 | 0.080 |
Why?
|
Gastritis | 2 | 2004 | 381 | 0.080 |
Why?
|
Biliary Fistula | 1 | 2007 | 9 | 0.070 |
Why?
|
Hernia, Hiatal | 1 | 2007 | 67 | 0.070 |
Why?
|
Clinical Competence | 2 | 2014 | 1368 | 0.070 |
Why?
|
Mass Screening | 2 | 2006 | 1572 | 0.070 |
Why?
|
Bronchial Fistula | 1 | 2007 | 37 | 0.070 |
Why?
|
Biomarkers, Tumor | 1 | 2006 | 10641 | 0.070 |
Why?
|
Treatment Failure | 2 | 2000 | 1430 | 0.070 |
Why?
|
CA-19-9 Antigen | 1 | 2006 | 149 | 0.070 |
Why?
|
Debridement | 1 | 2006 | 124 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2000 | 2342 | 0.060 |
Why?
|
Observer Variation | 1 | 2007 | 713 | 0.060 |
Why?
|
Aged | 10 | 2017 | 73018 | 0.060 |
Why?
|
Conscious Sedation | 1 | 2006 | 105 | 0.060 |
Why?
|
Middle Aged | 11 | 2017 | 89661 | 0.060 |
Why?
|
Analgesia | 1 | 2006 | 95 | 0.060 |
Why?
|
Pancreatitis, Chronic | 1 | 2006 | 127 | 0.060 |
Why?
|
Colonic Diseases | 1 | 2005 | 74 | 0.060 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2004 | 7 | 0.060 |
Why?
|
Credentialing | 1 | 2005 | 63 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2005 | 67 | 0.060 |
Why?
|
Electrosurgery | 1 | 2004 | 28 | 0.060 |
Why?
|
Equipment Design | 2 | 2006 | 1229 | 0.060 |
Why?
|
Pancreatic Cyst | 1 | 2005 | 110 | 0.060 |
Why?
|
Dilatation | 1 | 2004 | 89 | 0.060 |
Why?
|
Arthritis | 1 | 2005 | 144 | 0.060 |
Why?
|
Esophageal Stenosis | 1 | 2004 | 87 | 0.060 |
Why?
|
Male | 13 | 2017 | 127769 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 517 | 0.050 |
Why?
|
Video Recording | 1 | 2005 | 276 | 0.050 |
Why?
|
Bisacodyl | 1 | 2002 | 1 | 0.050 |
Why?
|
Citric Acid | 1 | 2002 | 54 | 0.050 |
Why?
|
Nitrites | 1 | 2002 | 62 | 0.050 |
Why?
|
Societies, Medical | 2 | 2005 | 1406 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2007 | 667 | 0.050 |
Why?
|
Stomach Ulcer | 1 | 2002 | 94 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2006 | 364 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2005 | 451 | 0.050 |
Why?
|
Organometallic Compounds | 1 | 2002 | 195 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2018 | 34335 | 0.050 |
Why?
|
Diagnosis, Differential | 4 | 2007 | 4867 | 0.050 |
Why?
|
Acute Disease | 1 | 2006 | 2489 | 0.050 |
Why?
|
Gastric Acid | 1 | 2000 | 47 | 0.050 |
Why?
|
Specimen Handling | 1 | 2002 | 302 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2000 | 217 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2002 | 528 | 0.040 |
Why?
|
Ranitidine | 1 | 1999 | 35 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2006 | 1085 | 0.040 |
Why?
|
Tetracycline | 1 | 1999 | 89 | 0.040 |
Why?
|
Bismuth | 1 | 1999 | 81 | 0.040 |
Why?
|
Clarithromycin | 1 | 1999 | 119 | 0.040 |
Why?
|
Fiber Optic Technology | 1 | 1999 | 147 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 4064 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2006 | 1178 | 0.040 |
Why?
|
Peptic Ulcer | 1 | 1999 | 144 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 5015 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2017 | 90 | 0.040 |
Why?
|
Neutrophils | 1 | 2002 | 850 | 0.040 |
Why?
|
Phosphates | 1 | 2017 | 188 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2005 | 1424 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1241 | 0.030 |
Why?
|
Age Factors | 1 | 2006 | 5498 | 0.030 |
Why?
|
Adult | 7 | 2009 | 80872 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 1377 | 0.030 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 1950 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 2877 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2005 | 6034 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 1999 | 1065 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 1999 | 1258 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2017 | 30845 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 636 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2014 | 92 | 0.030 |
Why?
|
Gastric Acidity Determination | 2 | 2004 | 16 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 1992 | 70 | 0.030 |
Why?
|
Varicose Veins | 1 | 1992 | 37 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2006 | 3258 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2004 | 598 | 0.030 |
Why?
|
Hypertension, Portal | 1 | 1992 | 128 | 0.020 |
Why?
|
Time Factors | 2 | 2009 | 13261 | 0.020 |
Why?
|
Recurrence | 1 | 1999 | 4889 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 3676 | 0.020 |
Why?
|
Biopsy | 2 | 2009 | 3502 | 0.020 |
Why?
|
Republic of Korea | 1 | 2009 | 76 | 0.020 |
Why?
|
Risk Factors | 1 | 2006 | 18036 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 1999 | 2487 | 0.020 |
Why?
|
Incidence | 2 | 2009 | 5893 | 0.020 |
Why?
|
Databases, Factual | 1 | 2014 | 2314 | 0.020 |
Why?
|
Pancreatic Pseudocyst | 1 | 2006 | 27 | 0.020 |
Why?
|
Calculi | 1 | 2006 | 16 | 0.020 |
Why?
|
Lithotripsy | 1 | 2006 | 23 | 0.020 |
Why?
|
Prognosis | 2 | 2009 | 22348 | 0.020 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2005 | 29 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2006 | 127 | 0.020 |
Why?
|
Celiac Plexus | 1 | 2005 | 14 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2007 | 833 | 0.020 |
Why?
|
Autonomic Nerve Block | 1 | 2005 | 15 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2006 | 326 | 0.020 |
Why?
|
Hospitalization | 1 | 2014 | 2220 | 0.020 |
Why?
|
Peritonitis | 1 | 2005 | 91 | 0.010 |
Why?
|
Lansoprazole | 1 | 2004 | 19 | 0.010 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2004 | 25 | 0.010 |
Why?
|
Bacterial Vaccines | 1 | 2004 | 104 | 0.010 |
Why?
|
Cholestasis | 1 | 2006 | 208 | 0.010 |
Why?
|
Survival Rate | 2 | 2009 | 12475 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 2302 | 0.010 |
Why?
|
Dyspepsia | 1 | 2004 | 107 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2005 | 151 | 0.010 |
Why?
|
Virulence | 1 | 2004 | 336 | 0.010 |
Why?
|
Administration, Rectal | 1 | 2002 | 14 | 0.010 |
Why?
|
Surgery, Computer-Assisted | 1 | 2005 | 266 | 0.010 |
Why?
|
Taste | 1 | 2002 | 52 | 0.010 |
Why?
|
Colonic Polyps | 1 | 2005 | 214 | 0.010 |
Why?
|
Naproxen | 1 | 2002 | 27 | 0.010 |
Why?
|
Interleukins | 1 | 2004 | 337 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2009 | 15255 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2005 | 703 | 0.010 |
Why?
|
Proton Pump Inhibitors | 1 | 2004 | 262 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2004 | 1031 | 0.010 |
Why?
|
Cell Count | 1 | 2002 | 508 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1398 | 0.010 |
Why?
|
Adolescent | 2 | 2014 | 32464 | 0.010 |
Why?
|
Stents | 1 | 2006 | 1159 | 0.010 |
Why?
|
Bacteremia | 1 | 2005 | 694 | 0.010 |
Why?
|
Infant | 1 | 2014 | 13889 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 1583 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 16882 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 10092 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2002 | 952 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 22268 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 3838 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1999 | 3512 | 0.010 |
Why?
|
Child | 1 | 2014 | 30357 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2007 | 5853 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 7765 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2007 | 4793 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2005 | 13883 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2009 | 39724 | 0.000 |
Why?
|
Prospective Studies | 1 | 1999 | 13336 | 0.000 |
Why?
|